Sunday, December 1, 2019

Biocon Biologics to reduce the cost of human insulin and cancer drugs

The Biocon subsidiary will chart a path that ensures high volumes and lowcosts, unlike competitors, Christiane Hamacher, chief executive of Biocon Biologics told ET. https://ift.tt/2RcdZVI https://ift.tt/eA8V8J
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

OpenAI and Google are providing advanced AI models to Singapore-based subsidiaries of Alibaba, Baidu, and Tencent, exposing a gap in US AI controls (Madhumita Murgia/Financial Times)

Madhumita Murgia / Financial Times : OpenAI and Google are providing advanced AI models to Singapore-based subsidiaries of Alibaba, Baidu...